Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Chromium Effects on Insulin and Vascular Function in People at Risk for Diabetes

NCT00067626 is registered in ClinicalTrials.gov with Griffin Hospital as lead sponsor.

NCT NCT00067626
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00067626 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Chromium Effects on Insulin and Vascular Function in People at Risk for Diabetes
Lead sponsor
Griffin Hospital
Phase
Phase 2
Overall status
Completed
Start date
April 30, 2005
Completion date
March 31, 2009
Enrollment
60 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

impaired fasting glucose, impaired glucose tolerance, insulin resistance, obesity, pre-diabetes